Discover 1,248 paid clinical trials in Nashville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Nashville offers many research opportunities for conditions such as diabetes, cardiovascular disease, and arthritis, giving participants access to innovative treatments and cutting-edge medical care. The city’s leading healthcare institutions are actively recruiting healthy volunteers for paid research studies, as well as individuals seeking trials for specific health concerns.
Filter
2
Filter results
Results: 1,248
Active & Responsive
Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing
for
Drug Allergy, Cephalosporin Allergy, Drug Hypersensitivity,
Location: Nashville TN, Dallas TX, Rochester NY, Boston MA,
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
for
Alpha1-Antitrypsin Deficiency
Location: Nashville TN, Birmingham AL, Indianapolis IN,
Sponsor: Takeda
Sex: All
Age: 18 - 70+
Code: NCT05677971
Phase3, Recruiting
Active & Responsive
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
for
Colorectal Cancer
Location: Nashville TN, Birmingham AL, Memphis TN, Atlanta GA,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06562543
Recruiting
Active & Responsive
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
for
Intestinal Neoplasms, Gastrointestinal Neoplasms,
Location: Nashville TN, Louisville KY, Mooresville IN, Athens GA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07222800
Phase3, Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Location: Nashville TN, Franklin TN, Lexington KY, Birmingham AL,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07198074
Phase3, Recruiting
Active & Responsive
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
for
Metastatic Dedifferentiated Liposarcoma,
Location: Nashville TN, Louisville KY, Centralia IL, Atlanta GA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06422806
Phase3, Recruiting
Active & Responsive
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
for
Recurrent Head and Neck Squamous Cell Carcinoma,
Location: Nashville TN, Louisville KY, Lexington KY, Atlanta GA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT04671667
Phase2, Recruiting
Active & Responsive
Evaluation of RBS2418 in Combination With Tremelimumab Plus Durvalumab in Participants With Advanced Unresectable Hepatocellular Carcinoma
for
Advanced Unresectable Hepatocellular Carcinoma
Location: Nashville TN, Baltimore MD, Dallas TX, Fort Worth TX
Sponsor: Riboscience, LLC.
Sex: All
Age: 18+
Code: NCT07175441
Phase2, Recruiting
Active & Responsive
Nemtabrutinib With CAR T Therapy in Relapsed/Refractory Mantle Cell Lymphoma